Search research articles
Contact Us
Filters
Showing results (521-530 of 573) with videos related to
Page
of 58
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
G Folprecht, C Pericay, M P Saunders, et al.
The Lancet. Oncology
|
December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
Thierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
The Lancet. Oncology
|
April 11, 2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose, Stephen Falk, Meg Finch-Jones, et al.
Frontiers in Psychiatry
|
April 17, 2026
Commercial or industrial use of mental health data for research: primer and best-practice guidelines from the DATAMIND patient/public Lived Experience Advisory Group
Linda A Jones, Corrine Barber, Naomi Clements-Brod, et al.
Clinical Colorectal Cancer
|
March 26, 2023
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)
Mark P Saunders, Rohan Iype, Caroline Kelly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 27, 2023
Artificial intelligence for dementia-Applied models and digital health
Donald M Lyall, Andrey Kormilitzin, Claire Lancaster, et al.
Cell Reports. Medicine
|
September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
Marta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
Julien Taieb, Debora Basile, Jenny Seligmann, et al.
The Lancet. Oncology
|
April 19, 2013
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell, Ian Chau, David Cunningham, et al.
The New England Journal of Medicine
|
July 11, 2006
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham, William H Allum, Sally P Stenning, et al.
Page
of 58
Search research articles
Search
Showing results (521-530 of 573) with videos related to
Sort By:
Page
of 58
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
G Folprecht, C Pericay, M P Saunders, et al.
The Lancet. Oncology
|
December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
Thierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
The Lancet. Oncology
|
April 11, 2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose, Stephen Falk, Meg Finch-Jones, et al.
Frontiers in Psychiatry
|
April 17, 2026
Commercial or industrial use of mental health data for research: primer and best-practice guidelines from the DATAMIND patient/public Lived Experience Advisory Group
Linda A Jones, Corrine Barber, Naomi Clements-Brod, et al.
Clinical Colorectal Cancer
|
March 26, 2023
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)
Mark P Saunders, Rohan Iype, Caroline Kelly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 27, 2023
Artificial intelligence for dementia-Applied models and digital health
Donald M Lyall, Andrey Kormilitzin, Claire Lancaster, et al.
Cell Reports. Medicine
|
September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
Marta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
Julien Taieb, Debora Basile, Jenny Seligmann, et al.
The Lancet. Oncology
|
April 19, 2013
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell, Ian Chau, David Cunningham, et al.
The New England Journal of Medicine
|
July 11, 2006
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham, William H Allum, Sally P Stenning, et al.
Page
of 58